Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2024

Genmab — Februar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #200

    Better deals were possible every step of the way

    1 Reply Last reply
    0
    • JørgenVarnæsJ Offline
      JørgenVarnæsJ Offline
      JørgenVarnæs
      wrote on sidst redigeret af
      #201

      GEN hasn't missed one single step in messing up values

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #202

        I think you are unbelievable harsh in your criticism of Genmab JV - its still one of the most successful biotechs in Europe

        1 Reply Last reply
        0
        • JørgenVarnæsJ Offline
          JørgenVarnæsJ Offline
          JørgenVarnæs
          wrote on sidst redigeret af
          #203

          Seriously - take out dara and cash from the valuation and you are left with dust and tubleweeds. Is that the hallmark of a successful R&D organization?

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #204

            Its time GEN starts earning its keep for the shareholders

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #205

              You cannot put a finger on the Scientific side of genmab. It’s been an unprecedented world class succes. Their wiilingness to pay out to shareholders however is far from satisfying.

              1 Reply Last reply
              0
              • JørgenVarnæsJ Offline
                JørgenVarnæsJ Offline
                JørgenVarnæs
                wrote on sidst redigeret af
                #206

                Please note, that I'm not questioning the quality of the research - I'm questioning the business decisions following the research

                1 Reply Last reply
                0
                • JørgenVarnæsJ Offline
                  JørgenVarnæsJ Offline
                  JørgenVarnæs
                  wrote on sidst redigeret af
                  #207

                  Am I completely wrong in saying, that the current GEN valuation is made up ENTIRELY from cash and expected dara-derived royalties?

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #208

                    Genmab is not to be blamed for the current Price. It’s not Long ago it was +3000. Business hasn’t changed since then.

                    1 Reply Last reply
                    0
                    • JørgenVarnæsJ Offline
                      JørgenVarnæsJ Offline
                      JørgenVarnæs
                      wrote on sidst redigeret af
                      #209

                      No? I beg to differ

                      1 Reply Last reply
                      0
                      • JørgenVarnæsJ Offline
                        JørgenVarnæsJ Offline
                        JørgenVarnæs
                        wrote on sidst redigeret af
                        #210

                        When Verdult says he still has respect for GEN leadership - but dara has been gifted to the partner and hexacd38 is closed country, he is really saying - there is not much respect left

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #211

                          GEN1046 Safety Trial has gone from Recruiting -to - Active, not recruiting https://classic.clinicaltrials.gov/ct2/history/NCT03917381?A=26&B=27&C=merged#StudyPageTop

                          1 Reply Last reply
                          0
                          • T Offline
                            T Offline
                            Teller
                            wrote on sidst redigeret af
                            #212

                            To be honest - My greatest concern is the deal made on super Dara. Was the same lawyers used for this deal??

                            1 Reply Last reply
                            0
                            • W Offline
                              W Offline
                              w
                              wrote on sidst redigeret af
                              #213

                              i asked Carlsen about this, regarding a sub version

                              1 Reply Last reply
                              0
                              • W Offline
                                W Offline
                                w
                                wrote on sidst redigeret af
                                #214

                                Hi Martin,
                                Hexabody CD38 is currently intravenous but can be made to SC by JnJ

                                1 Reply Last reply
                                0
                                • T Offline
                                  T Offline
                                  Teller
                                  wrote on sidst redigeret af
                                  #215

                                  You not only have to be a good scientist and be able to develop new and wonderful drugs. You also and importantly have to be extremely "Street-smart" in a legal sense.

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gdn55
                                    wrote on sidst redigeret af
                                    #216

                                    Er dette ikke en dansk chat?

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #217

                                      Sc hex 38 er i hvert fald et nyt statement. Winkel er blevet spurgt flere gange, og sagt, at det var for tidligt at afgøre.

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        KWC
                                        wrote on sidst redigeret af
                                        #218

                                        Konkurence ? https://www.biospace.com/article/gsk-s-blenrep-scores-phase-iii-win-in-multiple-myeloma/?utm_campaign=Daily Social | News&utm_content=281354534&utm_medium=social&utm_source=facebook&hss_channel=fbp-10530620221

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          KWC
                                          wrote on sidst redigeret af
                                          #219

                                          GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper